Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Moonlake Immunotherapeutics (MLTX)

Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Moonlake Immunotherapeutics DORFSTRASSE 29 ZUG V8 6300 CHE

www.moonlaketx.com Employees: 100 P: 41-41-510-8022

Sector:

Medical

Description:

MoonLake Immunotherapeutics AG is a clinical-stage biotechnology company. It focused on creating next-level therapies for inflammatory skin and joint diseases. MoonLake Immunotherapeutics AG, formerly known as Helix Acquisition Corp., is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 890,884
Enterprise Value, $K 710,454
Shares Outstanding, K 64,231
Annual Sales, $ 0 K
Annual Net Income, $ -118,940 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -69,730 K
EBIT, $ -229,200 K
EBITDA, $ -227,820 K
60-Month Beta 1.21
% of Insider Shareholders 12.02%
% of Institutional Shareholders 93.85%
Float, K 56,510
% Float 87.98%
Short Interest 4,270
Short Float 6.65%
Short Volume Ratio 0.61

Growth:

1-Year Return -73.67%
3-Year Return 32.10%
5-Year Return 25.86%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.10 on 11/05/25
Next Earnings Date 02/25/26
Earnings Per Share ttm -3.32
EPS Growth vs. Prev Qtr -26.44%
EPS Growth vs. Prev Year -96.43%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

MLTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -55.57%
Return-on-Assets % -45.18%
Profit Margin % 0.00%
Debt/Equity 0.25
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.03
Book Value/Share 4.53
Interest Coverage -2.99
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar